165 results
8-K
EX-99.1
AORT
Artivion Inc
11 Jul 14
Departure of Directors or Certain Officers
12:00am
to execute on our growth strategy and, personally, I am greatly looking forward to working with him.”
Pat Mackin commented, “In CryoLife, I found the right … to the growth strategy and I am excited by the opportunity to become part of a great team and feel privileged to join the CryoLife family as we work
8-K
EX-99.1
AORT
Artivion Inc
3 May 18
Results of Operations and Financial Condition
12:00am
and JOTEC posted non-GAAP revenue growth of 20 percent. We believe that this growth confirms that our strategy of focusing on highly differentiated products … incremental margin benefit from our direct sales strategy.”
Mr. Mackin added, “We remain excited about the R&D pipeline from JOTEC, as we continue advancing
8-K
EX-99.1
AORT
Artivion Inc
6 Dec 23
Artivion Appoints Lance A. Berry as Announces Retirement of D. Ashley Lee, Chief Financial Officer
4:23pm
background in, among other areas, strategy, M&A, financing, business development, digital strategy and investor relations.
“I am thrilled to welcome Lance … Artivion and its strategy through our next stage of growth.”
“I am excited to join Artivion as Chief Financial Officer and continue my commitment to driving
8-K
EX-99.2
AORT
Artivion Inc
29 Mar 11
Entry into a Material Definitive Agreement
12:00am
million in 2010]
Slide Nine
Growth Strategy
Increase addressable market opportunity
Expand product offerings to cardiac and vascular surgeons through … products and the markets into which those products are distributed, CryoLife’s growth strategy and its product pipeline. These statements also include
425
EX-99.3
AORT
Artivion Inc
9 Feb 10
Business combination disclosure
12:00am
an exit strategy that provides value to existing Medafor shareholders. At the same time, as Medafor’s largest distributor, we feel that integrating … plan to continue to communicate with Medafor shareholders directly about our offer for Medafor and our strategy for the company going forward.
What
8-K
EX-99.2
tj081lq1hs
2 Nov 06
CryoLife Reports Profitable Third Quarter 2006
12:00am
8-K
EX-99.3
8a8j3j
9 Feb 10
Other Events
12:00am
8-K
EX-99.2
v8vki9t35 szutd7
2 Feb 10
Other Events
12:00am
425
EX-99.2
xfhzr cjlc2xv46ht
2 Feb 10
Business combination disclosure
12:00am
8-K
EX-99.1
vwthyx1 u44q7l
30 Apr 19
Results of Operations and Financial Condition
4:11pm
425
EX-99.1
86a40oe1
11 Mar 10
Business combination disclosure
12:00am
8-K
EX-99.1
5iavwiy87u
4 Nov 20
Results of Operations and Financial Condition
4:10pm
8-K
EX-99.1
8kkwx6xtlfw4au
11 Mar 10
Important Information for Medafor Shareholders
12:00am
8-K
EX-99.1
6kzmrg1ljxh8 hoil1
29 Mar 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.2
20727o0b9b4il
11 Mar 10
Important Information for Medafor Shareholders
12:00am
8-K/A
EX-99.2
4p7ls 4sikf
23 Feb 15
Results of Operations and Financial Condition
12:00am
425
EX-99.2
mgada4
11 Mar 10
Business combination disclosure
12:00am
8-K
EX-99.1
id1 xodq3ee
29 Oct 13
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
nke9ij 1wk
20 Jun 18
Departure of Directors or Certain Officers
7:22am